Paul E. Verweij

Research interests

Publications

• Tackling the emerging threat of antifungal resistance to human health

  Nature Reviews Microbiology · 2022 · https://doi.org/10.1038/s41579-022-00720-1

• Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

  Intensive Care Medicine · 2020 · https://doi.org/10.1007/s00134-020-06091-6

• Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

  The Lancet Infectious Diseases · 2020 · https://doi.org/10.1016/s1473-3099(20)30847-1

• COVID-19–associated Pulmonary Aspergillosis

  American Journal of Respiratory and Critical Care Medicine · 2020 · https://doi.org/10.1164/rccm.202004-1038le

• Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

  Clinical Infectious Diseases · 2019 · https://doi.org/10.1093/cid/ciz1008

• Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

  The Lancet Respiratory Medicine · 2018 · https://doi.org/10.1016/s2213-2600(18)30274-1

• Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

  Clinical Microbiology and Infection · 2018 · https://doi.org/10.1016/j.cmi.2018.01.002

• Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus

  mSphere · 2017 · https://doi.org/10.1128/msphere.00238-17

• Prospective Multicenter International Surveillance of Azole Resistance inAspergillus fumigatus

  Emerging infectious diseases · 2015 · https://doi.org/10.3201/eid2106.140717

• Azole Resistance in Aspergillus fumigatus : Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

  Clinical Infectious Diseases · 2015 · https://doi.org/10.1093/cid/civ885

• ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

  Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12515

• ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

  Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12465

• ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

  Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12371

• ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

  Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12039

• Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus

  PLoS ONE · 2012 · https://doi.org/10.1371/journal.pone.0031801

• ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

  Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12038

• Clinical Implications of Azole Resistance inAspergillus fumigatus, the Netherlands, 2007–2009

  Emerging infectious diseases · 2011 · https://doi.org/10.3201/eid1710.110226

• Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

  Clinical Infectious Diseases · 2009 · https://doi.org/10.1086/598327

• Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

  The Lancet Infectious Diseases · 2009 · https://doi.org/10.1016/s1473-3099(09)70265-8

• Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

  Applied and Environmental Microbiology · 2009 · https://doi.org/10.1128/aem.00231-09

• EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

  Clinical Microbiology and Infection · 2008 · https://doi.org/10.1111/j.1469-0691.2007.01935.x

• Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

  PLoS Medicine · 2008 · https://doi.org/10.1371/journal.pmed.0050219

• The Effects of Tibolone in Older Postmenopausal Women

  New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0800743

• Multiple-Triazole–Resistant Aspergillosis

  New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmc061720

• A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations

  Antimicrobial Agents and Chemotherapy · 2007 · https://doi.org/10.1128/aac.01092-06

• Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

  The Lancet Infectious Diseases · 2004 · https://doi.org/10.1016/s1473-3099(04)01045-x

Current projects

No projects listed.